Member Info for Brainer

So you said: “I think it will rise first thing”
What going to make it rise? Clearly that’s what making you jealous as you couldn’t buy in as cheap as us! Keep getting burnt, good night

Hey shut up fool, you have disgusting thoughts, you don’t know nothing about me or this company, I have provided proof of research, not lies. You are nothing but a jealous troll

I don’t think you can read mr lol, if you can then you would’ve been able to see “Based on Last result”,
However, market will value whatever is appropriate, we will find out soon

Mr lol, do you know how to read? You all of sudden appear with your lol comment and never answer anything, did you buy when it was 50p?

London Stock Exchange valued the companies Net Asset Value per Share (exc. Intangibles) 4.02p based on last result, which doesn’t include current drag programs, Licence, main market listing, potential, and stronger cash position and increased institutional holdings and support to advance the company.

Source: https://www.londonstockexchange.com/exchange/prices/stocks/summary/fundamentals.html?fourWayKey=GG00BD3FV870GGGBXSSQ3

So just can’t see it going anywhere below current level, more chance of 20p with only 2.87% free float!

http://okyopharma.com/content/about/directors-management

Just can’t see it going below current price, a retrace was due as most people bought seeing it rising without any research whatsoever, now some people researched and likely to buy tomorrow and many other will jump in seeing it’s rising. It didn’t rise back on Friday for few reasons: most people don’t like buying when it’s down and at low price, some were too scared, most importantly Friday is a profit taking day!

Obviously they meant incremental value for institutional holder as only 2.87% left on free float for people like us!

CORPORATE STRATEGY
OKYO Pharma Limited (LSE: OKYO) is a life sciences and biotechnology company admitted to listing on the standard segment of the Official List of the UK Financial Conduct Authority and to trading on the Main Market for listed securities of the London Stock Exchange plc.
OKYO Pharma’s future strategy is to differentiate itself by focusing on opportunities where clinical development timelines are short. It is the intention that OKYO Pharma will work closely with its retained clinicians with a view to generating incremental value for its shareholders.

‘Company acquired the benefit of a licence from Tufts of the right to exploit all of the intellectual property relating to the development of the endogenous peptide BAM-8 (“BAM-8”)’

patent WO2017014605 being claims in composition of matter and methodology for treating, inter alia, ocular inflammation, dry eye disease and ocular neuropathic pain with Chemerin or a fragment of analog thereof and a lipid entity linked to the Chemerin’

Chemarin project the BAM-8 peptide IP is Big As proved by recent medial research

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036347/

http://www.pnas.org/content/by/volume/1

Predator, I have been keeping eye on wrn since it’s suspension and tired of waiting now lol

Scully, all the stock are risky, some of them takes months or years to rise 50% and days or hours to go back down, very long term holders mostly make loss, I prefer going for stock that will return short or medium term, otherwise it’s hard to survive in this market. In most situations risky ones pays more, you just need to time it well, not saying I always time well!

Predator, can’t see okyo doing 150 bagger like WRN but can see it doing 5 to 10 bagger easy!

I Did make 200% on a £3k investment from WRN having bought at 15p and sold at 45p same day when it did 25 bagger from 2p to 50p in one day, on next day it did drop back below 30p before the crazy ride to 300p.
that was the craziest thing I have ever witnessed in my life lol, however didn’t see 300p was coming, so didn’t hold till then, Are they ever coming back? Been 4 years!

Do you know what WRN did on Admission to main market? It went from 2p to 300p in 6 weeks!

Northern explorer, wellcome new addition of fool in this B.B. it’s not imaginary check and calculate

Institutions holds 67.13% :- Panetta Partners 47.95% + regent marchentile 6.24% + James Mellon 6.09%+ rosey mining 6.85% = 67.13%

Share held in nominees account: Beaufort Nominees 22% + PLINIAN CAPITAL LIMITED 8% = 30%

Held by institutions and nominees: 67.13% + 30% = 97.13%, so free float only 2.87%!

You are comparing with AIQ! AIQ did 20 bagger but OKYO only did 1 bagger so far, so 19 bagger more to come then?

You are calling us investor fool means you are calling all the institutional holders fool, do you realise that makes you the worst fool to appear in this chat board?

Having only 2.87% free float with all this institutions on board, any good news at all will make it bag every 5 minutes, and we are expecting few updates on deal, update on devoloping drags, I can’t see it going one% lower then 4p but can see it doing anything crazy like 20p to 40p! happy to hold, fortune favours the brave!

correction

Institutions holds 67.13%Today 10:32Institutions holders: Panetta Partners 47.95% + regent marchentile 6.24% + James Mellon 6.09%+ rosey mining 6.85% = 67.13%

Share held in nominees account: Beaufort Nominees 22% + PLINIAN CAPITAL LIMITED 8% = 30%

Held by institutions and nominees: 67.13% + 30% = 97.13%, so free float only 2.87%!

That’s why big spread as only 2.87% free float, question is: why all this large institutions on board? Mid capital Pharma company in the making, it will do many bagger in one day with any awaited deal news.

Institutions holders: Panetta Partners 47.95% + regent marchentile 6.24% + James Mellon 6.09%+ rosey mining 6.85% = 67.13%

Share held in nominees account: Beaufort Nominees 22% + PLINIAN CAPITAL LIMITED 8% = 30%

Free float 67.13% + 30% = 97.13%, so free float only 2.87%!

That clearly means, they meant to write 32% is in public hand and approximately 68% isn’t.

However, if the 22% from Beaufort nominees not available to trade then available to trade share is 10.45% only

So that takes the free float down to 2.55% wow, it seems Okyo isn’t much bothered to keep the pi up to date as it’s all about institution holder!

http://www.lse.co.uk/share-regulatory-news.asp?shareprice=WAFM&ArticleCode=xj4kphzl&ArticleHeadline=Holdings_in_Company

Fortune favours the brave, no risk no reward! Most importantly most of them has more risk but less reward chance, with okyo having so many institutions on board and such low free float rewards can be sweet at its best!